Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies

Dr Emily Sammons

Dr Emily Sammons

Contact information


emily.sammons@ndph.ox.ac.uk

Emily Sammons

BSc, MBChB, MSc

Clinical Research Fellow

Dr Emily Sammons is a Clinical Research Fellow and DPhil student at the Clinical Trial Service Unit & Epidemiological Studies Unit (CTSU), with particular research interests in diabetic eye disease and age-related macular degeneration.

Alongside this, she works on two large randomised controlled trials: ASCEND and REVEAL.

ASCEND is studying whether aspirin and omega-3 fish oil supplementation protects against cardiovascular disease in people with diabetes.

REVEAL is assessing the safety and benefits of taking a new lipid-modifying drug called anacetrapib, by those with pre-existing atherosclerotic vascular disease.

Emily has background experience of working in General Medicine and a MSc in Public Health.

Recent publications

More publications